GELS

GELTEQ LIMITED

GELS·Q3978B109·US·Common Stock·Healthcare - Drug Manufacturers - Specialty & Generic

GELS (GELTEQ LIMITED) is held by 4 institutional investors as of Q1 2026. Largest holders: Private Advisor Group, LLC ($11,018), CITADEL ADVISORS LLC ($8,991), TWO SIGMA INVESTMENTS, LP ($6,644). Net institutional sentiment: Mixed.

4
Holders
Avg rating(1 Elite)
$27,865
Total Value
60% (5)
Fund Consensus
3 buying - 2 selling

No verdict yet — fewer than 2 funds hold GELS.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used